MDRNA Issued Chinese Patent on Use of Nucleic Acids to Treat Cancer

The patent describes the modulation of claudins, which are proteins associated with tumor progression and metastasis.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.